StonvexLoading…
StonvexStonvexStonvexCore line items from CPB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-01 | Q4 2025 2025-11-02 | Annual 2025 2025-08-03 | Q2 2025 2025-04-27 |
|---|---|---|---|---|
Revenue | $5.24B | $2.68B | $10.25B | $7.93B |
Operating Income | $609.00M | $336.00M | $1.12B | $855.00M |
Net Income | $339.00M | $194.00M | $602.00M | $457.00M |
EPS (Diluted) | $1.13 | $0.65 | $2.01 | $1.52 |
Total Assets | $15.35B | $15.18B | $14.90B | $14.83B |
Total Liabilities | $11.34B | $11.22B | $10.99B | $10.96B |
Cash & Equivalents | $561.00M | $168.00M | $132.00M | $143.00M |
Free Cash Flow OCF − CapEx | $513.00M | $97.00M | $705.00M | $576.00M |
Shares Outstanding | 299.00M | 299.00M | 300.00M | 300.00M |